Novel manganese (II) complex based on EDTA coordination cage bearing benzothiazole aniline (BTA) moiety with high chelation stability was designed and synthesized for use as a liver-specific MRI contrast agent. In addition to forming a hydrophilic, this new hepatobiliary Mn(II) chelate is rapidly taken up by hepatocyte of liver. The magnetic and kinetic properties of Mn(II) complex are higher than commercially available analogue, Mn-DPDP, which was clinically approved MR liver contrast agent. The complex, Mn-EDTA-BTA, was evaluated via in vivo MR imaging to prove high tumor detection sensitivity using animal liver tumor model.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords